WST

221.22

0.54% -1.20

Dopo l'orario di chiusura: 221.22

West Pharmaceutical Services Inc (WST)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WST Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$222.42

Aprire:

$223

Volume 24 ore:

501.32K

Relative Volume:

0.63

Capitalizzazione di mercato:

$16.36B

Reddito:

$2.90B

Utile/perdita netta:

$467.20M

Rapporto P/E:

34.73

EPS:

6.37

Flusso di cassa netto:

$306.90M

1 W Prestazione:

+0.09%

1M Prestazione:

+5.65%

6M Prestazione:

-32.63%

1 anno Prestazione:

-31.43%

Intervallo 1D:

$218.78

$224.15

Intervallo di 1 settimana:

$215.66

$226.79

Portata 52W:

$187.43

$352.33

West Pharmaceutical Services Inc Stock (WST) Company Profile

Nome

West Pharmaceutical Services Inc

Settore

Healthcare (1166)

Industria

Medical Instruments & Supplies (61)

Telefono

(610) 594-2900

Indirizzo

530 HERMAN O. WEST DRIVE, EXTON, PA

Dipendente

10,600

Cinguettio

@WestPharma

Prossima data di guadagno

2024-10-24

Ultimi documenti SEC

WST's Discussions on Twitter

Confronta WST con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WST West Pharmaceutical Services Inc	221.22	16.36B	2.90B	467.20M	306.90M	6.37
ISRG Intuitive Surgical Inc	540.60	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	177.27	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	89.30	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	255.88	37.05B	5.02B	1.31B	1.56B	8.91

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-18	Iniziato	Evercore ISI	Outperform
2025-02-14	Aggiornamento	Deutsche Bank	Hold → Buy
2025-01-08	Iniziato	Citigroup	Buy
2024-12-13	Iniziato	Wolfe Research	Peer Perform
2024-12-12	Aggiornamento	UBS	Neutral → Buy
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Aggiornamento	BofA Securities	Neutral → Buy
2023-04-11	Aggiornamento	Stephens	Equal-Weight → Overweight
2022-12-14	Iniziato	Deutsche Bank	Hold
2022-11-30	Iniziato	UBS	Neutral
2022-10-28	Downgrade	BofA Securities	Buy → Neutral
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-10-14	Iniziato	Stephens	Equal-Weight
2020-07-21	Aggiornamento	BofA Securities	Neutral → Buy
2020-04-24	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-12-12	Downgrade	BofA/Merrill	Neutral → Underperform
2019-07-26	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-05-01	Downgrade	Jefferies	Buy → Hold
2019-04-23	Iniziato	William Blair	Outperform
2018-04-25	Downgrade	BofA/Merrill	Neutral → Underperform
2018-01-24	Iniziato	Goldman	Neutral
2017-10-17	Downgrade	BofA/Merrill	Buy → Neutral
2017-10-03	Iniziato	Stephens	Equal-Weight
2017-09-15	Aggiornamento	Jefferies	Hold → Buy
2016-10-28	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-09-21	Downgrade	Wells Fargo	Outperform → Market Perform
2016-03-22	Iniziato	Wells Fargo	Outperform
2010-05-14	Reiterato	UBS	Neutral
2010-02-23	Iniziato	Jefferies & Co	Buy
2008-12-19	Iniziato	UBS	Neutral

Mostra tutto

West Pharmaceutical Services Inc Borsa (WST) Ultime notizie

Jun 18, 2025

KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth - Investing.com

Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - FinancialContent

Jun 18, 2025

Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline - ACCESS Newswire

Jun 18, 2025

KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth By Investing.com - Investing.com UK

Jun 18, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - FinancialContent

Jun 18, 2025

Jun 17, 2025

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jun 17, 2025

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Jun 17, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider

Jun 17, 2025

Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Reminds Investors of July 7, 2025 - ACCESS Newswire

Jun 17, 2025

Is West Pharmaceutical Services Stock Underperforming The Nasdaq? - Barchart.com

Jun 17, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders - PR Newswire

Jun 17, 2025

Jun 16, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm - Morningstar

Jun 16, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Jun 16, 2025

2025-06-16 | Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action | NYSE:WST | Press Release - Stockhouse

Jun 16, 2025

Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire

Jun 16, 2025

Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView

Jun 16, 2025